Immuno-genetic screening to improve cancer therapies and developing novel antibody drugs 1-10 Employees
- B2B
- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
- Website
- Locations
- Company size
- 1-10 people
- Total raised
- $150K
- Company type
- Private Company
- Markets
Svastia Genetics careers
Svastia is a digital platform to improve cancer therapies and discover new drugs through immuno-genetic screening of cancer patients. Svastia combines the power of conventional DNA sequencing, along with immuno-sequencing of T-cell and B-cell repertoires.
Svastia offers AI-driven cancer treatment selection and relapse prediction for clinical trials and FDA-approved therapies, and also learns novel patterns of treatment response from the patient data. At the same time, sequencing the immune repertoire enables us to identify neutralizing antibodies that can be developed as novel drugs for cancer and other diseases.
Svastia offers AI-driven cancer treatment selection and relapse prediction for clinical trials and FDA-approved therapies, and also learns novel patterns of treatment response from the patient data. At the same time, sequencing the immune repertoire enables us to identify neutralizing antibodies that can be developed as novel drugs for cancer and other diseases.
Svastia Genetics hasn't added any jobs yet
Get notified when Svastia Genetics posts new jobs.
Prem Achuthan
Parthiban Vijayarangakannan
Expert in Genomics, Cancer therapy with business experience. Have a PhD from Max-Planck (Germany) and worked as a postdoc in Cambridge(UK).
Total raised
$150K
Funded over
1 round
Latest round
Pre-Seed (Feb 2019)
MoodMe • Silicon Valley • 1 week ago
Audicus • New York City • $50k – $60k • No equity • 2 weeks ago
AllTrails • Remote • 4 weeks ago
Movable Ink • Remote • 4 weeks ago
Brightidea, Inc. • San Francisco • 4 weeks ago